U.S. says 2 die after Biogen, Genentech drug
445922
Two lupus patients died from a rare brain infection after taking the Genentech and Biogen Idec drug Rituxan, U.S. health officials said in an advisory issued on Monday.
33587
Amgen Inc. and Johnson & Johnson anemia drugs will carry strong new warnings after studies showed a higher risk of death and life-threatening side effects in some patients, U.S. health officials said on Friday.
132487
For those that missed it last night, Biogen Idec (BIIB:Nasdaq - news - research) and Elan Pharmaceuticals (ELN:NYSE ADR - news - research) received FDA approval for their new multiple sclerosis drug, now called Tysabri (formerly known as Antegren.
603826
Biotechnology companies Genentech Inc. and OSI Pharmaceuticals Inc. on Thursday said U.S. regulators have approved their drug Tarceva as a treatment for the most common form of lung cancer.
745602
Genentech Inc colon and lung cancer  drug Avastin, along with standard chemotherapy, increases  survival rates of patients with a very deadly type of brain  tumor, U.S. researchers said on Thursday.
186503
The government and Genentech are warning doctors that Avastin, which is used to treat colorectal cancer, increases patients' risk of potentially lethal heart ailments.
423243
The US National Institutes of Health halted an Alzheimer&#39;s prevention study of Pfizer Inc.&#39;s Celebrex painkiller and the generic naproxen drug because of a heart risk.
476212
On Thursday, biotechnology companies Genentech Inc. and OSI Pharmaceuticals Inc. said US regulators have approved their drug Tarceva for treating the most common form of lung cancer.
348867
A 2-year-old boy who died from kidney failure last month had been infected with the same strain of E. coli bacteria that prompted a nationwide consumer warning on fresh spinach and sickened at least 192 people.
153052
The deaths of two patients prescribed a powerful painkiller as a headache treatment were among four fatalities linked to the recently approved drug, its manufacturer reported Thursday.
252263
Pfizer Inc. on Friday said patients taking its blockbuster arthritis drug Celebrex in a long-term cancer-prevention trial had more than twice the number of fatal or non-fatal heart attacks as those taking a placebo.
676044
The US Food and Drug Administration (FDA) issued a warning about the generic drug naproxen, after the National Institutes of Health (NIH) halted a clinical trial involving patients at risk of developing Alzheimers.
166500
Merck &amp; Co. pulls the drug when a study finds it doubles the risk of heart attack and strokes. Tucsonan Carolyn White feels the pain of rheumatoid arthritis in just about every major joint in her body - shoulders
139290
Biogen Idec Inc., the third-biggest US biotechnology company, reported a fourth-quarter profit of $48.4 million, helped by sales of its Avonex and Tysabri multiple-sclerosis treatments. Net income was 14 cents a share compared with a net loss of $990.6 million, or $4.03, a year earlier, the Cambridge company said. Revenue almost doubled to $586 million. Biogen is counting on Tysabri, ...
499175
At least one person has died after being injected with a purported treatment for Lyme disease, health officials said Friday in warning doctors and patients to avoid the unapproved product.
380448
Biotech company OSI Pharmaceuticals Inc. and biotech giant Genentech Inc. reported Friday that the Food and Drug Administration approved their Tarceva cancer treatment for patients with advanced non-small-cell
348515
The 36-year-old Illinois woman who died last month after being treated with an experimental gene therapy was infected with a fungus that usually causes only a mild illness. But the infection spun out of control and ravaged her organs, suggesting that her immune system was seriously impaired, said...